Table 4. Univariate analysis of anticholinergic use at 30 days.

Analysis of Maximum Likelihood Estimates
Parameter	Estimate	Standard Error	Pr > χ2	OR	95% CI
Age	0.00903	0.0876	0.9179	1.009	0.850 – 1.198
Sex (male vs. female)	0.9414	0.4431	0.0336	2.563	1.076 – 6.109
Total number of diagnosesa	0.1827	0.1518	0.2285	1.201	0.892 – 1.616
Total number of Axis I diagnosesb	0.4980	0.2434	0.0408	1.646	1.021 – 2.652
Antipsychotic classc	2.6731	0.5431	<.0001	14.485	4.996 – 42.000
Daily antipsychotic dose at initiationd	0.00110	0.000527	0.0367	1.001	1.000 – 1.002
Daily antipsychotic dose at one monthd	0.00100	0.000489	0.0407	1.001	1.000 – 1.002

^aTotal number of medical and psychiatric diagnoses recorded in the medical record at the most recent primary care and psychiatry notes of treating physicians

^bChart documented psychiatric diagnoses categorized in the Diagnostic and Statistics Manual for Psychiatric Disorders Text Revision

^cFGA or polypharmacy vs. SGA

^dDose in chlorpromazine equivalents